Author

Jong Hoon Shin

Institution: SK bioscience Co., Ltd. (South Korea)

Observed institution: SK bioscience Co., Ltd. (South Korea)

ORCID: 0000-0002-9042-7408

Observed ORCID: 0000-0002-9042-7408

OpenAlex ID: A5012820582

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

2021 · Ganesh Kumar Rai, Tarun Saluja, et al. · The Lancet Infectious Diseases · 37

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

2022 · Maria Rosario Capeding, Birkneh Tilahun Tadesse, et al. · npj Vaccines · 12

Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9–15 months old Nepalese infants

2022 · Tarun Saluja, Ganesh Kumar Rai, et al. · Vaccine · 10

Immune persistence after 5 years of vaccination by Vi-DT vaccine among children below 2 years: Result from long-term observational study

2025 · Rejwana Haque Pial, Maria Rosario Capeding, et al. · Vaccine · 2

Longevity of immune-response provided by at least one dose of vi-DT vaccine 5 years after vaccination among healthy Filipino adults and children

2025 · Rejwana Haque Pial, Maria Rosario Capeding, et al. · Vaccine

Works count: 5

Citation count: 61

H-index: 3

I10-index: 3